A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.

Clinical trial NCT05752123 · TERMINATED

Trial details

NCT number: NCT05752123
Sponsor: EdiGene (GuangZhou) Inc.
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Transfusion Dependent Beta-Thalassaemia

Start date: 2023-02-18
Primary completion: 2024-01-29
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.